Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Adrenal Gland Neoplasms

• Phase II Study of PD-1 Inhibitor Combined With Apatinib and Mitotane in the Treatment of Advanced Adrenal Cortical Carcinoma
• Agnostic Therapy in Rare Solid Tumors
• Study in Children and Adolescents of 177Lu-DOTATATE (Lutathera) Combined with the PARP Inhibitor Olaparib for the Treatment of Recurrent or Relapsed Solid Tumours Expressing Somatostatin Receptor (SSTR) (LuPARPed).
• SPI-62 as a Treatment for Hypercortisolism Related to a Benign Adrenal Tumor
• Prospective Exploratory Study of FAPi PET/CT With Histopathology Validation in Patients With Various Cancers
• Surgery of Subclinical Cortisol Secreting Adrenal Incidentalomas
• Phase 1 Study of ATR-101 in Subjects With Advanced Adrenocortical Carcinoma
• A Pilot Study of F-18 Paclitaxel (FPAC) PET for Evaluating Drug Delivery of Solid Tumors in Breast, Lung, Renal, and Adrenal Cancers
• A Phase II Study of Pertuzumab and Erlotinib for Metastatic or Unresectable Neuroendocrine Tumors
• Evaluation of 123I-Iodometomidate for Adrenal Scintigraphy
• Iodine I-131 Iodocholesterol, Its Use in Adrenal Screening